This is a news story, published by Guardian, that relates primarily to IVF news.
For more drug discoveries news, you can click here:
more drug discoveries newsFor more news from Guardian, you can click here:
more news from GuardianOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
embryo implantation success. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest new fertility drug news, fertility treatment news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
embryo implantationGuardian
•83% Informative
The pill, known as OXO-001, is designed to act directly on the lining of the womb to make it more receptive to the embryo being implanted.
The findings raise hope for patients who have experienced repeated implantation failures during successive rounds of IVF .
The drug did not appear to have negative side effects and, in the six-month follow-up, the babies had healthy development.
VR Score
85
Informative language
84
Neutral language
70
Article tone
semi-formal
Language
English
Language complexity
59
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
2
Source diversity
1
Affiliate links
no affiliate links